Cited by 217Gut microbiota and healthMetabolism and Genetic DisordersMetabolomics and Mass Spectrometry Studies

Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control

Mueller, Daniel M., Allenspach, Martina, Othman, Alaa, Saely, Christoph H., Muendlein, Axel, Vonbank, Alexander, Drexel, Heinz, von Eckardstein, Arnold·2015·Atherosclerosis

Abstract

Background After ingestion of phosphatidylcholine, l-carnitine or betaine, trimethylamine-N-oxide (TMAO) is formed by gut microbiota and liver enzymes. Elevated TMAO plasma levels were associated with increased cardiovascular risk and other diseases. Also betaine and choline itself were recently associated with increased cardiovascular risk.Methods A newly developed LC-HRMS method was applied to measure the plasma concentrations of TMAO, betaine and choline in a cohort of 339 patients undergoing coronary angiography for the evaluation of suspected coronary artery disease.Results Betaine concentrations in males were significantly higher than in females (42.0 vs. 35.9 μmol/L; p < 0.001). Plasma concentrations of TMAO but not of betaine or choline were higher in patients with diabetes compared to euglycemic patients (2.39 vs. 0.980 μmol/L; p = 0.001) as well as in patients with metabolic syndrome as compared to patients without metabolic syndrome (2.37 vs. 1.43 μmol/L; p = 0.002). Plasma concentrations of TMAO or choline increased significantly with decreasing renal function (Spearman's rho: -0.281; p < 0.001). However, plasma levels of TMAO or betaine were associated with neither a history of myocardial infarction nor the angiographically assessed presence of coronary heart disease, nor incident cardiovascular events during 8 years of follow-up. Plasma levels of choline were significantly lower in patients with a history of acute myocardial infarction as compared to those without such history (10.0 vs. 10.8 μmol/L; p = 0.045).Conclusions Plasma levels of TMAO are confounded by impaired kidney function and poor metabolic control but are not associated with the history, presence or incidence of symptoms or events of coronary heart disease.

Integrity signals

Registry

Crossref · 10.1016/j.atherosclerosis.2015.10.091

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Mueller, D. M., Allenspach, M., Othman, A., Saely, C. H., Muendlein, A., Vonbank, A., Drexel, H., & von Eckardstein, A.
Affiliations
  • University of Zurich (CH)
  • Landeskrankenhaus Feldkirch (AT)
Venue
Atherosclerosis
Publisher
Elsevier BV
Published
2015-12
Volume
243
Issue
2
Pages
638-644
ISSN
0021-9150 (ISSN-L)
OpenAlex
W1751395982
Cited by
217
References
46
Citations by year
2026: 6 · 2025: 10 · 2024: 18 · 2023: 21 · 2022: 30 · 2021: 19 · 2020: 36 · 2019: 18 · 2018: 20 · 2017: 20 · 2016: 18 · 2015: 1
FWCI
8.54
Type
journal article
Language
en
Open access
closed
Locations
  • Atherosclerosis (publishedVersion)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
Keywords
trimethylamine N-oxide, betaine, choline, plasma biomarkers, renal function, renal dysfunction, metabolic control, diabetes mellitus, metabolic syndrome, coronary artery disease, myocardial infarction, cardiovascular risk, gut microbiota
MeSH terms
Aged, Betaine, Blood Glucose, Choline, Chromatography, Liquid, Coronary Disease, Diabetes Mellitus, Female, Glomerular Filtration Rate, Humans, Kidney, Male, Methylamines, Middle Aged, Predictive Value of Tests, Prognosis, Time Factors, Reproducibility of Results, Biomarkers, Coronary Angiography, Spectrometry, Mass, Electrospray Ionization, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review